Netherlands· NL-457b8cc4db95
Actilyse 50 mg, poeder en oplosmiddel voor oplossing voor injectie en infusie
A alteplase product containing alteplase, registered in Netherlands by Originalis B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Alteplase is registered in 14 of 19 countries.
Countries holding a registration under ATC B01AD02 (alteplase), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Alteplase · ATC B01AD02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of alteplase costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Alteplase · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- FI Finland$2204.37
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ALTEPLASE
- Manufacturer
- Originalis B.V.
- Country
- Netherlands (NL)
- ATC code
- B01AD02
- ATC class
- Alteplase
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id122903//12248
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
146 interactions on record for alteplase.
Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Alteplase · interactions on record
146 records
- 49 severe
- 97 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Alteplase in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomActilyse 10mg powder and solvent for solution for injection vialsBoehringer Ingelheim Ltd
- FinlandActilyseOrifarm Oy
- Japanアルテプラーゼ(遺伝子組換え)田辺ファーマ
- BelgiumActilyse 10 mg/10 mlBoehringer Ingelheim
- SwitzerlandActilyse 10mg, Pulver und Lösungsmittel zur Herstellung einer Injektions-/InfusionslösungBoehringer Ingelheim (Schweiz) GmbH
- IrelandActilyse 10 mg powder and solvent for solution for injection and infusionBoehringer Ingelheim International GmbH
- NorwayActilyseBoehringer lngelheim International GmbH
- CzechiaACTILYSEBoehringer Ingelheim International GmbH, Ingelheim am Rhein
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Actilyse, Actilyse Cathflo
- Belgium · Actilyse, Actilyse Cathflo
- Bulgaria · Актилизе
- Cyprus · Actilyse, Actilyse Cathflo
- Czechia · Actilyse
- Germany · Actilyse, Actilyse Cathflo
- Denmark · Actilyse
- Estonia · Actilyse
- Spain · Actilyse
- Finland · Actilyse
- France · Actilyse
- United Kingdom (Northern Ireland) · Actilyse, Actilyse Cathflo
- Greece · Actilyse, Actilyse Cathflo
- Croatia · Actilyse
- Hungary · Actilyse
- Ireland · Actilyse, Actilyse Cathflo
- Iceland · Actilyse
- Italy · Actilyse
- Lithuania · Actilyse
- Luxembourg · Actilyse, Actilyse Cathflo
- Latvia · Actilyse
- Malta · Actilyse
- Norway · Actilyse
- Poland · Actilyse 10, Actilyse 20
- Portugal · Actilyse, Actilyse Cathflo
- Romania · Actilyse
- Sweden · Actilyse
- Slovenia · Actilyse, Actilyse Cathflo
- Slovakia · Actilyse
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b49b31b1-bcf4-4f51-9cfb-9136b94dca4a GET /v1/drugs/b49b31b1-bcf4-4f51-9cfb-9136b94dca4a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder en oplosmiddel voor oplossing voor injectie",
"route": null,
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h12248_smpc.pdf",
"strength": null,
"atc_label": "Alteplase",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg122903",
"excipients": [
"ARGININE, (L-)",
"FOSFORZUUR (E 338)",
"POLYSORBAAT 80 (E 433)",
"WATER VOOR INJECTIE"
],
"substances": [
"ALTEPLASE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h122903.pdf",
"authorised_at": "2018/05/23",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "122903//12248",
"additional_monitoring": "N"
}See everything about alteplase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.